https://clinicaltrials.gov/ct2/show/NCT04056897?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14
Condition : Multiple Sclerosis
Interventions : Biological: BCD-132, 125 mg; Drug: Teriflunomide; Drug: Placebo; Biological: BCD-132, 500 mg
Sponsor : Biocad
Recruiting
Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis
NCT04056897
Wed, 14 Aug 2019 12:00:00 EDT
First Added: 08/14/19 07:50AM
